يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"pathology: Neoplasm Recurrence"', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: College of Medicine, Dept. of Radiation Oncology, Seo Hee Choi, Jee Suk Chang, Hong In Yoon, Dong-Su Jang, Nam Kyu Kim, Joon Seok Lim, Byung So Min, Hyuk Huh, Sang Joon Shin, Joong Bae Ahn, Woong Sub Koom, Koom, Woong Sub, Kim, Nam Kyu, Min, Byung Soh, Shin, Sang Joon, Ahn, Joong Bae, Yoon, Hong In, Lim, Joon Seok, Chang, Jee Suk Paul, Choi, Seo Hee, Hur, Hyuk

    Relation: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; J01283; OAK-2018-02012; https://ir.ymlib.yonsei.ac.kr/handle/22282913/162377; https://link.springer.com/article/10.1007%2Fs00432-018-2624-6; T201801479; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, Vol.144(6) : 1119-1128, 2018; 59961

  2. 2

    المصدر: Acta neuropathologica 140(6), 893-906 (2020). doi:10.1007/s00401-020-02218-7
    Acta Neuropathologica

  3. 3

    المساهمون: von Minckwitz, Gunter, Puglisi, Fabio, Cortes, Javier, Vrdoljak, Eduard, Marschner, Norbert, Zielinski, Christoph, Villanueva, Cristian, Romieu, Gille, Lang, István, Ciruelos, Eva, DE LAURENTIIS, Michelino, Veyret, Corinne, de Ducla, Sabine, Freudensprung, Ulrich, Srock, Stefanie, Gligorov, Joseph

    المصدر: The Lancet Oncology. 15:1269-1278

    مصطلحات موضوعية: Oncology, Time Factors, genetic structures, medicine.medical_treatment, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, genetics, skin and connective tissue diseases, Humanized, education.field_of_study, Medicine (all), drug therapy/genetics/mortality/pathology, Remission Induction, Middle Aged, Metastatic breast cancer, Bevacizumab, Treatment Outcome, Local, Retreatment, metastatic breast cancer, Drug, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Combination therapy, Population, Breast Neoplasms, Antibodies, Monoclonal, Humanized, administration /&/ dosage/adverse effects, Antibodies, Disease-Free Survival, Drug Administration Schedule, methods, Dose-Response Relationship, Breast cancer, Internal medicine, medicine, Humans, Neoplasm Invasiveness, education, Survival analysis, Aged, erbB-2, drug therapy/mortality/pathology, Neoplasm Staging, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Patient Selection, Genes, erbB-2, medicine.disease, Survival Analysis, eye diseases, Neoplasm Recurrence, Genes, pathology, sense organs, Neoplasm Recurrence, Local, business, Adult, Aged, Antibodies, administration /&/ dosage/adverse effects, Antineoplastic Combined Chemotherapy Protocols, administration /&/ dosage/adverse effects, Breast Neoplasms, drug therapy/genetics/mortality/pathology, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Follow-Up Studies, Genes, genetics, Humans, Maximum Tolerated Dose, Middle Aged, Neoplasm Invasiveness, pathology, Neoplasm Recurrence, drug therapy/mortality/pathology, Neoplasm Staging, Patient Selection, Remission Induction, methods, Retreatment, Survival Analysis, Time Factors, Treatment Outcome, Follow-Up Studies

  4. 4
  5. 5
    Academic Journal
  6. 6

    المصدر: American Journal of Obstetrics and Gynecology. 199:642.e1-642.e6